Gland Pharma

2,797.40

-21.90

(-0.78%)

Market Cap

46,145.82 Cr

PE Ratio

41.22

Volume

3,20,138.00

Day High - Low

2,880.00 - 2,793.30

52W High-Low

3,039.80 - 1,573.60

compare with

Sun Pharmaceutical

1,911.40 (+0.47%)

Divis Laboratories

8,515.00 (-0.95%)

Torrent Pharmaceuticals

4,875.50 (-0.43%)

Cipla

1,424.50 (-0.54%)

Zydus Life Science

1,102.20 (-1.59%)

Key Fundamentals

Market Cap

46,145.82 Cr

EPS

62.35

PE Ratio

41.22

PB Ratio

4.49

Book Value

627.88

EBITDA

1,945.90

Dividend Yield

0.71 %

Industry

Healthcare

Sector

Pharmaceuticals

Return on Equity

9.92

Debt to Equity

0.03

Actual

Company News

View All News

Gland Pharma schedules investor meetings for Aug 26-27

1 day ago

Gland Pharma has announced one-on-one meetings with Nomura and HDFC MF on August 26 and 27, 2026, in compliance with SEBI LODR regulations.

Gland Pharma appoints Deepak Sapra as CEO

10 days ago

Gland Pharma Ltd has appointed Deepak Sapra as its new Chief Executive Officer, effective November 16, 2026. Sapra brings 27 years of experience, including over two decades in the pharmaceutical sector.

Gland Pharma Q1 Results: Net Profit Up to ₹3.17B YoYAug 10, 2026

Gland Pharma posts Q1 net profit of ₹3.17B vs ₹2.2B YoY, revenue rises to ₹18B from ₹15B, and EBITDA margin expands to 27.18% from 24.42%.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,911.40	#1 4,58,608.89	37.64	#1 61,673.90	12.69	#1 11,565	26.53	43.08
Divis Laboratories	8,515.00	2,26,046.50	77.60	11,067.00	13.95	2,568	65.50	73.35
Torrent Pharmaceuticals	4,875.50	1,85,448.35	86.11	13,886.20	20.34	2,138	3.28	48.73
Cipla	1,424.50	1,15,077.57	34.33	29,044.60	2.24	3,870	-39.18	45.95
Zydus Life Science	1,102.20	1,10,907.11	24.33	27,657.90	17.64	5,026	-34.90	48.15
Lupin	2,188.00	1,00,042.48	#1 18.06	29,038.90	#1 26.75	5,356	16.00	29.34
Dr Reddys Laboratories	1,184.50	98,866.55	30.81	35,058.60	3.90	4,158	-69.10	43.08
Mankind Pharma	2,371.10	97,925.48	47.38	14,636.40	14.85	1,938	29.13	39.76
Laurus Labs	1,801.40	97,249.76	89.92	6,867.80	22.01	890	#1 123.93	60.02
Aurobindo Pharma	1,625.00	93,498.91	25.36	34,145.20	5.56	3,503	25.21	54.01

Automatic Screeners on ScanX

Day 1 Unusual Volume

10% near 52 Week High

Resistance 1 Breached

Growth Rate

Revenue Growth

15.73 %

Net Income Growth

47.07 %

Cash Flow Change

12.75 %

ROE

30.01 %

ROCE

20.10 %

EBITDA Margin (Avg.)

13.41 %

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
25 Aug 2026	Annual General Meeting	NA	25 Aug 2026	1,898.20	2,820.40
16 Aug 2024	Dividend	₹ 20.00 /share	16 Aug 2024	1,800.25	1,958.25
30 Aug 2024	Annual General Meeting	NA	30 Aug 2024	1,800.25	1,849.00
04 Nov 2024	Quarterly Result Announcement	NA	04 Nov 2024	1,675.30	1,644.85
03 Feb 2025	Quarterly Result Announcement	NA	03 Feb 2025	1,672.75	1,530.45
20 May 2025	Quarterly Result Announcement	NA	20 May 2025	1,418.75	1,484.15
05 Aug 2025	Quarterly Result Announcement	NA	05 Aug 2025	2,000.80	1,982.80
14 Aug 2025	Dividend	₹ 18.00 /share	14 Aug 2025	1,484.15	1,950.30
28 Aug 2025	Annual General Meeting	NA	28 Aug 2025	1,484.15	1,928.25
03 Nov 2025	Quarterly Result Announcement	NA	03 Nov 2025	1,917.60	1,928.90
28 Jan 2026	Quarterly Result Announcement	NA	28 Jan 2026	1,698.95	1,675.90
15 May 2026	Quarterly Result Announcement	NA	15 May 2026	1,794.40	1,898.20
10 Aug 2026	Quarterly Result Announcement	NA	10 Aug 2026	2,377.70	2,600.45
11 Aug 2026	Dividend	₹ 20.00 /share	11 Aug 2026	1,898.20	2,667.30

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
SBI Quality Fund Direct-Growth	0.00%	-69689	-0.72%	0.00%
Samco Small Cap Fund Direct-Growth	3.19%	14477	2.05%	2.84%
WhiteOak Capital Aggressive Hybrid Fund Direct-Growth	0.23%	3976	0.23%	0.23%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth	0.93%	687	-0.01%	0.04%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct-Growth	2.60%	364	0.10%	0.72%
Groww Nifty Smallcap 250 Momentum Quality 100 Index Fund Direct-Growth	2.70%	93	0.21%	2.70%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth	0.46%	47	0.01%	0.00%
DSP Nifty Smallcap 250 Index Fund Direct-Growth	0.92%	42	-0.01%	0.04%
JioBlackRock Sector Rotation Fund Direct-Growth	0.15%	-33	-0.01%	0.02%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.09%	-5	-0.01%	0.00%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth	0.31%	-1	-0.01%	0.02%
Kotak Healthcare Fund Direct-Growth	2.75%	0	0.00%	0.54%
ICICI Prudential Equity & Debt Fund Direct-Growth	0.00%	0	0.00%	0.00%
Axis Large & Mid Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%
Axis Multicap Fund Direct-Growth	0.49%	0	0.00%	0.49%
Axis Nifty 500 Index Fund Direct-Growth	0.10%	0	0.00%	0.00%
Axis Nifty Smallcap 50 Index Fund Direct-Growth	2.49%	0	0.00%	-0.13%
Axis Small Cap Fund Direct-Growth	0.79%	0	0.00%	-0.02%
Axis Value Fund Direct-Growth	0.49%	0	0.00%	0.49%
Bandhan BSE Healthcare Index Fund Direct-Growth	1.23%	0	0.00%	-0.03%
Bandhan Large & Mid Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bandhan Nifty Midcap 150 Index Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth	0.93%	0	0.00%	0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth	0.10%	0	0.00%	0.00%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth	1.20%	0	0.07%	0.79%

Technical Indicators

RSI(14)

Neutral

62.23

ATR(14)

Less Volatile

92.17

STOCH(9,6)

Neutral

56.82

STOCH RSI(14)

Neutral

20.72

MACD(12,26)

Bullish

1.16

ADX(14)

Strong Trend

44.46

UO(9)

Bearish

47.15

ROC(12)

Uptrend And Accelerating

10.77

WillR(14)

Neutral

-43.35

About Gland Pharma

Gland Pharma Limited is an Indian generic injectables manufacturer specializing in sterile injectables, oncology, and ophthalmic products. Founded in 1978, the company operates primarily on a B2B model, selling products in over 60 countries. It has 8 manufacturing facilities in India, including 4 for finished formulations and 3 for APIs....more

Listing Date

20 Nov, 2020(5 Years, 9 Months, 4 Days)

Website

https://www.glandpharma.com

Chairperson NameSRINIVAS SADU

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Gland Pharma

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Corporate Action

Mutual Fund Holdings

Technical Indicators

About Gland Pharma